{
    "2018-08-14": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer Expected to Report Robust EPS Rise in Fiscal 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Robust EPS Rise",
                        "Fiscal 2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "How IBMâ€™s Global Business Services Unit Is Doing",
                "features": {
                    "keywords": [
                        "IBM",
                        "Global Business Services",
                        "Unit Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pfizer Is Expected to Report Modest Revenue Rise in Fiscal 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Modest Revenue Rise",
                        "Fiscal 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}